A Multicenter, Randomized, Double-Blind, Actively Controlled Trial to Evaluate the Safety and Efficacy of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium 3.3g Bid vs. Mesalamine (5-ASA) As Asacol 0.8 G Tid ub Mildly to

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/066/30/09